Neurones SA
PAR:NRO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
40.25
47.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Neurones SA
Neurones SA
Gross Profit
Neurones SA
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Neurones SA
PAR:NRO
|
Gross Profit
€774.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Sopra Steria Group SA
PAR:SOP
|
Gross Profit
€4.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
15%
|
|
|
Capgemini SE
PAR:CAP
|
Gross Profit
€6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Alten SA
PAR:ATE
|
Gross Profit
€3.7B
|
CAGR 3-Years
18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
|
Societe Pour l Informatique Industrielle SA
PAR:SII
|
Gross Profit
€726.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
|
Exclusive Networks SAS
PAR:EXN
|
Gross Profit
€481m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neurones SA
Glance View
Neurones SA, a formidable player in the European IT services landscape, operates with a keen focus on providing a diverse array of technological solutions that help organizations adapt to evolving business environments. Founded in the late 1980s, this Paris-based enterprise has grown to encompass a network of subsidiaries, each specializing in various domains of information technology and digital transformation. By maintaining a robust and versatile portfolio, Neurones SA effectively caters to sectors spanning from banking and insurance to telecommunications, healthcare, and public administration. The company’s innovative approach is built on a delicate balance of software integration, IT infrastructure management, and consulting services, ensuring clients not only adapt to change efficiently but also gain a competitive edge in their respective industries. Revenue generation for Neurones SA primarily hinges on delivering consultancy and project services that tailor technological advancements to specific client needs. The firm thrives by offering bespoke solutions that leverage cloud computing, cybersecurity, big data analytics, and digital user experience enhancements. Often, these projects commence with an in-depth assessment of a client’s existing systems and business strategies, leading to the blueprinting of comprehensive IT roadmaps aimed at elevating operational efficiency. By executing such targeted services, Neurones SA not only fortifies client relationships but also secures long-term contracts and recurring revenue flows, thereby cementing its financial foundation and sustaining growth momentum in an ever-competitive marketplace.
See Also
What is Neurones SA's Gross Profit?
Gross Profit
774.2m
EUR
Based on the financial report for Jun 30, 2024, Neurones SA's Gross Profit amounts to 774.2m EUR.
What is Neurones SA's Gross Profit growth rate?
Gross Profit CAGR 10Y
8%
Over the last year, the Gross Profit growth was 10%. The average annual Gross Profit growth rates for Neurones SA have been 11% over the past three years , 9% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
